Who is sponsoring NCT01478256?

NCT01478256 is sponsored by John, George, M.D..

What condition does NCT01478256 study?

NCT01478256 studies Blepharitis.

What drugs are being tested in NCT01478256?

Interventions: Erythromycin, Besifloxocin.

What is the status of NCT01478256?

NCT01478256 is currently COMPLETED.

Last reviewed 2013-11-20 · How we verify

A Comparative Study in the Clinical and Microbial Efficacy of Topical Besifloxocin Ophthalmic Suspension 0.6% With Erythromycin Ophthalmic Ointment 0.5% BID for the Management of Acute Blepharitis

NCT01478256 Phase 4 COMPLETED Results posted

This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of improvement.

Details

Lead sponsor	John, George, M.D.
Phase	Phase 4
Status	COMPLETED
Enrolment	30
Start date	2011-08
Completion	2011-10

Conditions

Blepharitis

Interventions

Erythromycin
Besifloxocin

Primary outcomes

Improvement in Signs and Symptoms of Blepharitis — Four weeks
Signs and symptoms of blepharitis were scored and determined before and after treatment with two different antibiotics

Countries

United States